Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.14 (
ATP synthase
)
7,042
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An increasing number of patients with nuclear genetic defects of mitochondrial
ATP synthase
have been identified in recent years. They are characterized by early onset, lactic acidosis, 3-methylglutaconic aciduria, hypertrophic cardiomyopathy and encephalopathy and most cases have a fatal outcome. Patient tissues show isolated defect of the
ATP synthase
complex and its content decreases to > or =30% of normal due to altered enzyme biosynthesis and assembly. Gene mapping and complementation studies have identified mutations in TMEM70 gene encoding a
30kD
mitochondrial protein of unknown function as the cause of the disease. An altered synthesis of this new ancillary factor in
ATP synthase
biogenesis was found in most of the known patients with decreased
ATP synthase
content. As revealed by phylogenetic analysis, TMEM70 is specific for higher eukaryotes.
...
PMID:TMEM70 protein - a novel ancillary factor of mammalian ATP synthase. 1910 53